Literature DB >> 9850566

Properties of the membranes containing the particulate methane monooxygenase from Methylosinus trichosporium OB3b.

M Takeguchi1, K Miyakawa, I Okura.   

Abstract

The particulate methane monooxygenase (pMMO) from Methylosinus trichosporium OB3b was partially purified and characterized by measuring the effects of reducing agents and additives, and the stability of pMMO was studied. Duroquinol was a suitable reducing agent, and pMMO was stabilized by bovine serum albumin (BSA). Among the additives, the copper (II) ion stimulated pMMO at low concentration and inhibited at high concentration. The optimum conditions for pMMO activity were as follows: 45 degrees C, pH 6.5 and 55 mM 3-morpholinopropanesulfonic acid (MOPS) buffer, and the rate of propene epoxide formation was 13.6 nmol min-1 mg-1 protein. ESR spectra indicate that the copper cluster in the membrane fraction is reduced by duroquinol and oxidized by dioxygen. The result suggests that the copper cluster is contained in the active site of pMMO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850566     DOI: 10.1023/a:1009278216452

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  3 in total

1.  The membrane-associated form of methane mono-oxygenase from Methylococcus capsulatus (Bath) is a copper/iron protein.

Authors:  Piku Basu; Bettina Katterle; K Kristoffer Andersson; Howard Dalton
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

2.  Comparison of EPR-visible Cu(2+) sites in pMMO from Methylococcus capsulatus (Bath) and Methylomicrobium album BG8.

Authors:  S S Lemos; M L Perille Collins; S S Eaton; G R Eaton; W E Antholine
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

3.  Identification of the valence and coordination environment of the particulate methane monooxygenase copper centers by advanced EPR characterization.

Authors:  Megen A Culpepper; George E Cutsail; William A Gunderson; Brian M Hoffman; Amy C Rosenzweig
Journal:  J Am Chem Soc       Date:  2014-08-08       Impact factor: 15.419

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.